Newsroom

top of page

Home / About / Newsroom

Newsroom

Press Releases

APF’s Community-Based Stigma Intervention Lowers Stigma and Increases Knowledge, Study Shows

APF’s Community-Based Stigma Intervention Lowers Stigma and Increases Knowledge, Study Shows

APF’s Community-Based Stigma Intervention Lowers Stigma and Increases Knowledge, Study Shows

National Organizations Urge the White House to Lift the Contingency Management Funding Cap

National Organizations Urge the White House to Lift the Contingency Management Funding Cap

National Organizations Urge the White House to Lift the Contingency Management Funding Cap

Breaking Barriers: New Explainer on the Science of Addiction Available in 12 Languages

Breaking Barriers: New Explainer on the Science of Addiction Available in 12 Languages

Breaking Barriers: New Explainer on the Science of Addiction Available in 12 Languages

Press Release: New Report Details Reductions in Addiction Stigma in Ohio

Press Release: New Report Details Reductions in Addiction Stigma in Ohio

Press Release: New Report Details Reductions in Addiction Stigma in Ohio

Press Release: Multilingual Fentanyl Awareness Resources Released

Press Release: Multilingual Fentanyl Awareness Resources Released

Press Release: Multilingual Fentanyl Awareness Resources Released

Announcing Anti-Stigma Initiative Sites

Announcing Anti-Stigma Initiative Sites

Announcing Anti-Stigma Initiative Sites

APF in the News

Mental Health and Recovery Board Seeks Input on Addiction

Mental Health Monday: Breaking substance abuse through the Anti-Stigma Initiative

DHMC selected as pilot site for nationwide Anti-Stigma Initiative

Knox County mental health officials ask residents to participate in survey

Kenosha County Substance Abuse Coalition selected as pilot site for Anti-Stigma Initiative

School leaders consider ordinance to stop vaping in schools

Dartmouth Hitchcock Medical Center selected as pilot site for nationwide Anti-Stigma Initiative

NYT: Narcan Safe to Sell Over-The-Counter

CNBC: FDA advisors recommend OTC Naloxone

bottom of page